Unknown

Dataset Information

0

Structural basis for the activation of PLC-? isozymes by phosphorylation and cancer-associated mutations.


ABSTRACT: Direct activation of the human phospholipase C-? isozymes (PLC-?1, -?2) by tyrosine phosphorylation is fundamental to the control of diverse biological processes, including chemotaxis, platelet aggregation, and adaptive immunity. In turn, aberrant activation of PLC-?1 and PLC-?2 is implicated in inflammation, autoimmunity, and cancer. Although structures of isolated domains from PLC-? isozymes are available, these structures are insufficient to define how release of basal autoinhibition is coupled to phosphorylation-dependent enzyme activation. Here, we describe the first high-resolution structure of a full-length PLC-? isozyme and use it to underpin a detailed model of their membrane-dependent regulation. Notably, an interlinked set of regulatory domains integrates basal autoinhibition, tyrosine kinase engagement, and additional scaffolding functions with the phosphorylation-dependent, allosteric control of phospholipase activation. The model also explains why mutant forms of the PLC-? isozymes found in several cancers have a wide spectrum of activities, and highlights how these activities are tuned during disease.

SUBMITTER: Hajicek N 

PROVIDER: S-EPMC7004563 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural basis for the activation of PLC-γ isozymes by phosphorylation and cancer-associated mutations.

Hajicek Nicole N   Keith Nicholas C NC   Siraliev-Perez Edhriz E   Temple Brenda Rs BR   Huang Weigang W   Zhang Qisheng Q   Harden T Kendall TK   Sondek John J  

eLife 20191231


Direct activation of the human phospholipase C-γ isozymes (PLC-γ1, -γ2) by tyrosine phosphorylation is fundamental to the control of diverse biological processes, including chemotaxis, platelet aggregation, and adaptive immunity. In turn, aberrant activation of PLC-γ1 and PLC-γ2 is implicated in inflammation, autoimmunity, and cancer. Although structures of isolated domains from PLC-γ isozymes are available, these structures are insufficient to define how release of basal autoinhibition is coupl  ...[more]

Similar Datasets

| S-EPMC2702322 | biostudies-literature
| S-EPMC3103399 | biostudies-literature
| S-EPMC4852598 | biostudies-literature
| S-EPMC7511445 | biostudies-literature
| S-EPMC3844103 | biostudies-literature
| S-EPMC10888979 | biostudies-literature
| S-EPMC2975207 | biostudies-literature
| S-EPMC3880865 | biostudies-literature
| S-EPMC3340281 | biostudies-literature
| S-EPMC2821964 | biostudies-literature